GKB Ophthalmics holds 44th AGM on Aug 25 with no dividend

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

GKB Ophthalmics conducts its 44th AGM on August 25, 2026, in Mapusa, Goa. The company proposes no dividend for FY25-26. Share transfer books close from August 19-25, with e-voting available until August 24.

powered bylight_fuzz_icon
47029430

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics will hold its 44th Annual General Meeting (AGM) on Tuesday, August 25, 2026, at 11:00 a.m. IST at its registered office in Mapusa, Goa. The company has confirmed that no dividend is proposed for the financial year 2025-26, indicating a strategy to retain capital rather than distribute profits to shareholders during this period. This decision impacts investor returns for the fiscal year ended March 31, 2026.

The Register of Members and Share Transfer Books will remain closed from Wednesday, August 19, 2026, to Tuesday, August 25, 2026, to finalize the list of shareholders eligible for the meeting. Shareholders holding units as of the end of business on Tuesday, August 18, 2026, are entitled to vote. During the closure period, no transfer of shares or registration of new members will be processed.

Key Dates and Details

Event Date
Book Closure Start August 19, 2026
Book Closure End August 25, 2026
44th AGM Date August 25, 2026
Dividend Proposed No

Shareholders can exercise their voting rights through remote e-voting or by attending the AGM in person. The remote e-voting period begins on Saturday, August 22, 2026, at 9:00 a.m. and concludes on Monday, August 24, 2026, at 5:00 p.m. The facility is provided by Central Depository Services (India) Limited (CDSL). Members who have already cast their votes via remote e-voting may attend the meeting but cannot vote again.

Regulatory Compliance and Voting Process

The book closure and AGM proceedings comply with Section 91 of the Companies Act, 2013, and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice for the AGM, along with the Annual Report for FY25-26, was dispatched electronically on Friday, July 31, 2026, to members with registered email addresses. For those without registered emails, a letter containing the web-link to the documents was sent.

Mr. Shivaram Bhat, a practicing Company Secretary (Membership No. 10454), has been appointed as the Scrutinizer to oversee the e-voting process. The results of the voting will be declared within 48 hours of the AGM's conclusion. Members holding shares in physical mode are requested to update their KYC details and email addresses with the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, using Form ISR-1 if they have not done so previously.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
+7.90%+3.75%0.0%0.0%0.0%0.0%

What specific capital allocation strategies or growth initiatives is GKB Ophthalmics prioritizing with the retained earnings from FY25-26?

How might the decision to forgo dividends impact GKB Ophthalmics' stock valuation and investor sentiment compared to peers in the ophthalmic sector?

Are there any pending regulatory approvals or strategic partnerships that could influence the company's financial outlook in the upcoming fiscal year?

GKB Ophthalmics receives Rs 8.82 Cr demand notice from Labour Commissioner

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

GKB Ophthalmics Ltd received a Notice of Demand on July 13, 2026, for Rs 8.82 Cr following a Labour Commissioner order dated September 04, 2025. The company plans to challenge the order in the Bombay High Court. The demand is linked to a 2021 Industrial Tribunal award currently under litigation.

powered bylight_fuzz_icon
45563927

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics Ltd received a Notice of Demand from the Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa on July 13, 2026, requiring the payment of Rs 8.82 Cr within 10 days. This demand arises from an order passed by the Labour Commissioner on September 04, 2025, for the recovery of funds from the company. The company intends to challenge the order before the Hon'ble High Court of Bombay by filing a writ petition seeking appropriate relief.

The development is related to ongoing litigation concerning an award passed by the Industrial Tribunal Panjim-Goa on May 25, 2021. The company is currently challenging this award through writ petition no. WP/358/2021 before the Hon'ble High Court of Bombay at Goa. Simultaneously, the matter was pending execution before the Labour Commissioner, leading to the recovery order and the subsequent demand notice.

The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Details of the Demand

The notice specifies a recovery amount of Rs 8.82 Cr and sets a strict deadline for payment. The company has clarified that it will consult with its legal counsel to contest the demand.

Particulars Details
Authority Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa
Date of Notice July 13, 2026
Amount Demanded Rs 8.82 Cr
Payment Deadline Within 10 days from July 13, 2026
Underlying Order Labour Commissioner Order dated September 04, 2025

Legal Proceedings

The company is actively involved in legal proceedings regarding the original award by the Industrial Tribunal. The filing of a new writ petition to challenge the recovery order represents the latest step in its legal strategy to manage the financial and operational implications of the case.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
+7.90%+3.75%0.0%0.0%0.0%0.0%

How will the immediate cash flow requirement of Rs 8.82 Cr impact GKB Ophthalmics' operational liquidity and working capital management?

What is the likelihood of the Hon'ble High Court granting a stay on the recovery order before the 10-day payment deadline expires?

If the company is unsuccessful in its legal challenge, what potential assets or business segments could be leveraged to satisfy the debt?

More News on GKB Ophthalmics

1 Year Returns:0.00%